In this issue:
Universal screening of both EC and CRC increases the detection of Lynch syndrome
Neoadjuvant chemotherapy followed by radical surgery vs concomitant chemotherapy and radiotherapy in locally advanced squamous cervical cancer
Oncologist-led BRCA mutation testing and counselling model for patients with ovarian cancer
HIPEC in ovarian cancer
Adjuvant chemoradiotherapy vs radiotherapy alone for women with high-risk endometrial cancer
Carboplatin-paclitaxel vs carboplatinpaclitaxel- trastuzumab in uterine serous carcinomas that overexpress HER2/neu
i.p. vs i.v. chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer
Clinical consequences of upfront pathology review in the PORTEC-3 trial
HRQOL with olaparib maintenance after chemotherapy in patients with ovarian cancer
Toxicity of intraperitoneal cisplatin and doxorubicin applied as PIPAC in recurrent ovarian cancer.
Efficacy and safety of oral NEPA in patients with gynaecological cancers receiving platinum-based chemotherapy
Please login below to download this issue (PDF)